BIOMAT Database Logo BIOMAT Database Logo

Early steroid withdrawal protocol using basiliximab in kidney transplantation. 2004

S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic

Related Publications

S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
January 2020, Transplantation proceedings,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
[Early steroid withdrawal after kidney transplantation].
September 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early steroid withdrawal after kidney transplantation.
June 1996, Transplantation proceedings,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early steroid withdrawal in repeat kidney transplantation.
February 2011, Clinical journal of the American Society of Nephrology : CJASN,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
December 2006, International immunopharmacology,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies.
February 2005, Clinical transplantation,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early steroid withdrawal in adult kidney transplantation at a single center.
January 2012, Transplantation proceedings,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Steroid avoidance or withdrawal in kidney transplantation.
December 2011, Current opinion in organ transplantation,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Successful DCD kidney transplantation using early corticosteroid withdrawal.
January 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
S Teraoka, and S Sato, and K Kai, and T Kawase, and M Nakamura, and T Tojinbara, and I Nakajima, and S Fuchinoue
Early steroid withdrawal after renal transplantation.
January 2006, Nephrology nursing journal : journal of the American Nephrology Nurses' Association,
Copied contents to your clipboard!